Effect of home‐based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial

Abstract

AbstractBackgroundMany patients with colon cancer cannot fully adhere to postoperative chemotherapy due to dose‐limiting toxicities, resulting in lower relative dose intensity (RDI) and potentially compromising overall survival. This study examined whether home‐based resistance training (RT) during adjuvant chemotherapy improves RDI and patient‐reported toxicities versus usual care (UC) in colon cancer patients.MethodsMulticenter, randomized control trial (RCT) conducted at community and academic practices. Enrollment of patients receiving postoperative chemotherapy for colon cancer occurred between February 23, 2018, and September 29, 2021; final follow‐up was March 21, 2022. Participants were randomized to RT (n = 90) or UC (n = 91) for the duration of chemotherapy. Participants in the RT group engaged in twice weekly home‐based progressive RT. At the end of the study, UC was given an online exercise program.ResultsAmong 181 randomized patients (mean age, 55.2 [SD, 12.8] years, 95 [52.5%] were men), there were no differences in the mean RDI among those in RT (79% [SD, 19%]) and those in UC (82% [SD, 19%]); (mean difference –0.04 [95% confidence interval (CI), –0.09 to 0.02]). Assignment to RT did not significantly reduce the number of moderate/severe symptoms per week across follow‐up (relative rate: 0.94 [95% CI, 0.72–1.22]). Additionally, time since randomization did not significantly modify the effect of RT on the overall number of symptoms (p = .06).ConclusionsAmong patients with colon cancer, these results do not support home‐based RT as an adjunct to chemotherapy specifically to improve planned treatment intensity.